FROM A LOCAL DISEASE TO A SYSTEMIC QUESTION
Local and systemic mechanisms
linking periodontal disease and
inflammatory comorbidities.
How microbial dissemination, systemic inflammation and bone-marrow adaptation may connect periodontitis with inflammatory comorbidities.
Volume 21 · 426–440 · 2021
DOI: 10.1038/s41577-020-00488-6
ORIGINAL PAPER · AT A GLANCE
Nature Reviews Immunology · Volume 21
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
George Hajishengallis · Triantafyllos Chavakis
The review connects epidemiology, clinical intervention studies and experimental models to examine how a dysbiosis-driven inflammatory disease in the mouth may initiate or aggravate disease at distant sites.
This is a PerioMed-designed bibliographic presentation and editorial synthesis, not a reproduction of the publisher’s first page or full abstract.
01 · THE QUESTION
When periodontal inflammation becomes systemic.
Can periodontitis contribute to inflammatory disease beyond the oral cavity, rather than simply coexist with it because of shared risk factors?
Hajishengallis and Chavakis move beyond the familiar observation that periodontitis is associated with several systemic conditions. They ask whether biological mechanisms can explain how a local, dysbiosis-driven inflammatory disease may initiate or aggravate disease at distant sites.
THE CENTRAL IDEA
A local inflammatory disease.
A body-wide immune response.
Periodontal pockets form chronically inflamed and ulcerated surfaces. Bacteria, microbial products and inflammatory mediators can enter the circulation, while persistent signals may also influence how immune cells are produced in the bone marrow.
MEMORYA possible shared mechanism
Inflamed periodontal tissues
A chronically ulcerated microbial–host interface.
Signals enter circulation
Bacteria, microbial products and inflammatory mediators travel beyond the mouth.
Bone-marrow adaptation
Inflammatory signals may increase myelopoiesis and influence immune-cell production.
More reactive immune cells
Neutrophils and monocytes may respond more strongly at local and distant sites.
WHAT CHANGES THE CONVERSATION
The bone marrow is not just a destination.
It may become a biological amplifier.
Chronic inflammatory signals may reprogramme haematopoietic stem and progenitor cells, increasing myelopoiesis and generating neutrophils and monocytes or macrophages that are more reactive to later inflammatory stimuli.
This concept, related to trained innate immunity, offers a plausible explanation for how inflammation at one mucosal site could have persistent consequences elsewhere in the body.
These cells can return to the periodontium or travel to other sites, potentially reinforcing inflammation in a self-sustaining biological loop.
CONDITIONS DISCUSSED
One mechanism.
Different levels of evidence.
The review does not present every association as equally established. It brings together multiple lines of research to explain where biological plausibility is strongest and where important questions remain.
Type 2 diabetes
The clearest bidirectional clinical relationship.
Cardiovascular disease
Plausible microbial and inflammatory pathways, with clinical causality still under study.
Rheumatoid arthritis
Shared inflammatory biology and immune mechanisms.
Inflammatory bowel disease
Possible interaction through disseminated microbes and altered immunity.
Neurodegeneration
An important but still developing field of investigation.
Metabolic disease
The liver and systemic metabolism may respond to chronic inflammatory signals.
NOT A ONE-WAY PATH
Systemic disease can also reshape periodontal health.
Type 2 diabetes offers the clearest example. Impaired metabolic control can intensify periodontal inflammation, while periodontal inflammation may add to the systemic inflammatory burden associated with diabetes.
INFLAMMATION↔SYSTEMIC AND
METABOLIC HEALTHShared biological, behavioural and social influences
WHAT THE REVIEW SUPPORTS
Connection with scientific restraint.
- Periodontitis can produce microbial and inflammatory signals beyond the oral cavity.
- Several pathways could contribute to systemic inflammatory burden.
- Bone-marrow adaptation offers a compelling model for persistent immune effects.
WHAT RESEARCH MUST STILL ESTABLISH
Mechanism is not the same as a clinical outcome.
- Evidence is not equally developed across all comorbidities.
- Improved biomarkers do not prove prevention of major systemic events.
- Long-term clinical studies remain essential.
PERIOMED BOTTOM LINE
“Periodontal inflammation begins locally. Its biological signals may not remain confined to the mouth.”
Periodontitis may represent a modifiable component of systemic inflammatory burden. Recognising this possibility does not require overstating causality. It requires placing periodontal health within interdisciplinary care for people living with chronic inflammatory and cardiometabolic conditions.